NasdaqGM - Nasdaq Real Time Price USD

Anbio Biotechnology Class A Ordinary Shares (NNNN)

Compare

6.61

+0.17

+(2.64%)

At close: April 17 at 4:00:00 PM EDT

6.44

-0.09

(-1.38%)

After hours: April 17 at 4:05:06 PM EDT

US Market's Top 3 Undiscovered Gems with Strong Fundamentals

The United States market has experienced a flat performance over the last week but has seen an 8.1% increase over the past year with earnings projected to grow by 14% annually. In this environment, stocks with strong fundamentals and growth potential stand out as promising opportunities for investors seeking to uncover hidden gems in the market.

Simply Wall St. 24 days ago

ICG

TRAK

NNNN
+2.64%
Undiscovered Gems In The US Featuring Anbio Biotechnology And 2 Other Small Caps

The United States market has remained flat over the past week but has shown a robust 21% increase over the last year, with earnings projected to grow by 14% annually. In this dynamic environment, identifying small-cap stocks like Anbio Biotechnology that possess strong growth potential and innovative capabilities can offer intriguing opportunities for investors seeking to uncover lesser-known gems.

Simply Wall St. last month

NPB

NNNN
+2.64%
DRD
Anbio Biotechnology Announces Closing of Initial Public Offering

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products, today announced the closing of its initial public offering (the “Offering”) of 1,600,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of US$5.00 per Class A Ordinary Share. The Class A Ordinary Shares began trading on the

GlobeNewswire last month

NNNN
+2.64%
Anbio Biotechnology Announces Pricing of Initial Public Offering

Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products, today announced the pricing of its initial public offering (the “Offering”) of 1,600,000 Class A ordinary shares (“the Class A Ordinary Shares”) at a public offering price of US$5.00 per Class A Ordinary Share. The Class A Ordinary Shares have been approved f

GlobeNewswire last month

NNNN
+2.64%

Performance Overview

Return	NNNN	S&P 500 (^GSPC)
YTD	+25.67%	-10.18%
1-Year	+25.67%	+5.19%
3-Year	+25.67%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Anbio Biotechnology Class A Ordinary Shares (NNNN)

US Market's Top 3 Undiscovered Gems with Strong Fundamentals

Undiscovered Gems In The US Featuring Anbio Biotechnology And 2 Other Small Caps

Anbio Biotechnology Announces Closing of Initial Public Offering

Anbio Biotechnology Announces Pricing of Initial Public Offering

Performance Overview